If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

GlaxoSmithKline (GSK), the consumer healthcare company, took a multifaceted approach to its COVID-19 response strategy, covering everything from content to media and e-commerce. Much like every other ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The UK company reveals the results from a partner-led survey to discover the rates ... examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID ...

(Bloomberg) -- GSK Plc and Flagship Pioneering Inc. entered a partnership to develop as many as 10 new drugs in a deal that ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

Delegates were welcomed by Dr Ken Lawrie (GlaxoSmithKline, UK, chair of the IIS UK group). The subsequent scientific programme consisted of oral and poster presentations on ... micronised ...

Reports also say the pneumonia outbreaks have led to school cancellations and some illnesses in ... said in the WHO statement that the wider launch of RTS,S produced by GSK, is a real game-changer in ...

GSK (NYSE:GSK) stock was up 3% in afternoon trading ... Zantac was pulled from the U.S. market in 2020 after the FDA was notified that the drug led to the formation of unacceptably high levels ...